The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.
D000284:Administration, Oral; D001647:Bile Acids and Salts / Q000378:metabolism*; D002635:Chenodeoxycholic Acid / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000494:pharmacology* / Q000627:therapeutic use; D002793:Cholic Acids / Q000378:metabolism; D002855:Chromatography, Thin Layer; D005260:Female; D006207:Half-Life; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000378:metabolism*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D014280:Triglycerides / Q000097:blood
D001647:Bile Acids and Salts; D002793:Cholic Acids; D008074:Lipoproteins; D014280:Triglycerides; D002635:Chenodeoxycholic Acid; D002792:Cholestyramine Resin; D002784:Cholesterol